The traditional method to identify suicide risk is based on oral conversations between caregivers and depressed patients and on statistical features of the patient and history of suicide attempts. Experiences show how difficult it is to find the risk patients with such approaches.
Emotra’s method, EDOR, is an objective and quantitative test, for the purpose of identifying hyporeactive persons. Results from clinical studies have shown that, as many as 97 per cent of the studied patients who have committed suicide were hyporeactive. This represents an undisputable strong relationship between hyporeactivity and risk for suicide.